13 unchanged sentences
aggregate offering price for the shares of common stock sold in the offering was approximately $26.2 million.
−Removed: We received net proceeds
−Removed: of approximately $23.3 million from the offering, after deducting underwriting discounts and commissions of approximately $1.8 million
−Removed: and offering expenses of approximately $1.1 million.
−Removed: No payments for the foregoing expenses were made by us to any of our officers, directors
−Removed: or persons owning ten percent or more of our common stock, or to the associates of any of the foregoing, or to its affiliates, other
−Removed: than payments in the ordinary course of business to our officers for salaries and bonuses.
−Removed: has been no material change in the planned use of proceeds as described in our Prospectus filed with the SEC on September 20, 2017.
−Removed: the Effective Date through September 30, 2021, we have used approximately $21.5 million in furtherance of our planned use of proceeds,
−Removed: which includes funding additional research and development for discovery of new cancer sub-types and development and validation of new
−Removed: CELsignia tests;
−Removed: clinical trials to support clinical claims;
+Added: received net proceeds of approximately $23.3 million from the offering, after deducting underwriting discounts and commissions of approximately
+Added: $1.8 million and offering expenses of approximately $1.1 million.
+Added: No payments for the foregoing expenses were made by us to any of our
+Added: officers, directors or persons owning ten percent or more of our common stock, or to the associates of any of the foregoing, or to its
+Added: affiliates, other than payments in the ordinary course of business to our officers for salaries and bonuses.
+Added: March 31, 2022, the net proceeds were used in furtherance of our planned use of proceeds, which includes funding additional research
+Added: and development for discovery of new cancer sub-types and development and validation of new CELsignia tests;
+Added: clinical trials to support
+Added: clinical claims;
development of operational processes and capital expenditures;
−Removed: capital and other general corporate purposes.
+Added: and working capital and other general corporate purposes.
+Added: As of March 31, 2022, all proceeds from the IPO have been utilized.
Unregistered Sales of Equity Securities
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.